Hemagen Diagnostics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

William Hales

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	25.2yrs
CEO ownership	n/a
Management average tenure	no data
Board average tenure	25.2yrs

Recent management updates

No updates

Recent updates

No updates

CEO

William Hales (62 yo)

25.2yrs

Tenure

US$192,348

Compensation

Mr. William P. Hales has been the Chief Executive Officer of Hemagen Diagnostics Inc., since March 2002 and has been its President since October 1, 1999. Mr. Hales served as the Principal Financial Officer...

Board Members

Name	Position	Tenure	Compensation	Ownership
William Hales	Executive Chairman	25.2yrs	US$192.35k	no data
Alan Cohen	Independent Director	31.9yrs	US$10.30k	no data
Edward Lutz	Independent Director	20.8yrs	US$10.30k	no data

25.2yrs

Average Tenure

77yo

Average Age

Experienced Board: HMGN's board of directors are seasoned and experienced ( 25.2 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 10:37
End of Day Share Price	2024/12/09 00:00
Earnings	2012/09/30
Annual Earnings	2012/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hemagen Diagnostics, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution